Skip to main content


Dosage form: liquid
Ingredients: Naphazoline hydrochloride 50mg in 100mL
Labeler: Sato Pharmaceutical Co., Ltd.
NDC code: 49873-057

Medically reviewed by Last updated on Aug 18, 2022.


Active ingredients
Naphazoline hydrochloride 0.05%

Purpose    Nasal decongestant

Uses for the temporary relief of nasal congestion due to the common cold, hay fever, or associated with sinusitis

For external use only

Do not use
■for more than 3 days
■in children under 12 years of age because it may cause sedation if swallowed

Ask a doctor before use if you have
■heart disease
■high blood pressure
■thyroid disease  ■diabetes
■difficulty in urination due to enlargement of the prostate gland

When using this product
■do not exceed recommended dosage
■if may cause temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge
■the use of this container by more than one person may spread infection
■use only as directed
■frequent or prolonged use may cause nasal congestion to recur or worsen

Stop use and ask a doctor if
■symptoms persist

If pregnant or breast-feeding, ask a health professional before use.

Keep our of reach of children.  In case of accidental overdose, get medical help or contact a Poison Control Center right away.

Adults and children 12 years of age and older - 1 or 2 sprays in each nostril not more often than every 6 hours
Children under 12 years of age -  do not give unless directed by a doctor

Other information  
■container is filled to proper level for best spray action

Inactive ingredients
benzalkonium chloride, citric acid, dibasic potassium phosphate, fragrance, monobasic potassium phosphate, simethicone, sodium chloride, water

naphazoline hydrochloride liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49873-057
Route of AdministrationNASALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Naphazoline hydrochloride (Naphazoline) Naphazoline hydrochloride50 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
benzalkonium chloride 
citric acid monohydrate 
potassium phosphate, dibasic 
potassium phosphate, monobasic 
silicon dioxide 
sodium chloride 
#Item CodePackage Description
1NDC:49873-057-011 BOTTLE in 1 CARTON
130 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34106/11/1990
Labeler - Sato Pharmaceutical Co., Ltd. (690575642)
Sato Pharmaceutical Co., Ltd.715699133manufacture(49873-057), label(49873-057), pack(49873-057)

Sato Pharmaceutical Co., Ltd.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.